Position in BMY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,144
+$109 QoQ
Shares Held
124
+6.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,445
of 2,506 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hurley Capital, LLC holds $903,759 across 9 Drug Manufacturers - General names. BMY ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,247 | $316,700 | |
| 2 | LLY |
ELI LILLY & Co
|
199 | $238,686 | |
| 3 | ABBV |
AbbVie Inc.
|
866 | $217,920 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
518 | $65,444 | |
| 5 | PFE |
Pfizer Inc
|
1,663 | $40,045 | |
| 6 | AMGN |
Amgen Inc
|
47 | $17,019 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
124 | $7,144 | |
| 8 | MRK |
Merck & Co., Inc.
|
4 | $514 |
All Filings in BMY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,144 | 124 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $7,035 | 116 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $12,028 | 223 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,682 | 126 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,369 | 116 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,074 | 116 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $6,560 | 116 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||